Numerous national surveys and surveillance programs have shown a substantial rise in the abuse of prescription opioids over the past 15 years. Accessibility of these drugs to non-patients is the result of their unlawful channeling from legal sources to the illicit marketplace (diversion). Empirical data on diversion remain absent from the literature. This paper examines abusers' sources of diverted drugs from two large studies: 1) a national sample of opioid treatment clients (N=1983), and 2) a South Florida study targeting diverse populations of opioid abusers (N=782). The most common sources of diverted medications were dealers, sharing/trading, legitimate medical practice (e.g., unknowing medical providers), illegitimate medical practice (e.g., pill mills), and theft, in that order. Sources varied by users' age, gender, ethnicity, risk-aversiveness, primary opioid of abuse, injection drug use, physical health, drug dependence, and either access to health insurance or relative financial wealth. Implications for prescription drug control policy are discussed.
Get full access to this article
View all access options for this article.
References
1.
AquilinoW.1994Interview mode effects in surveys of drug and alcohol use. Public Opinion Quarterly, 54, 362–395.
2.
AquilinoW.LoSciutoL.1990Effect of interview mode on self-reported drug use. Public Opinion Quarterly, 58, 210–240.
3.
BergmanU.Dahl-PuustinenM.L.1989Use of prescription forgeries in a drug abuse surveillance network. European Journal of Clinical Pharmacology, 36 (6), 621–623.
4.
BlumenscheinK.1997Prescription drug diversion: Fraudulent tactics utilized in the community pharmacy. American Journal of Pharmaceutical Education, 61 (2), 184–188.
5.
BorsackS.1986–87Hospital drug diversion: The verdict is in. Health Matrix, 4 (4), 27–31.
6.
BradenJ. B.RussoJ.FanM. Y.EdlundM. J.MartinB. C.DeVriesA.SullivanM. D.2010Emergency department visits among recipients of chronic opioid therapy. Archives of Internal Medicine, 170 (16), 1425–1432.
7.
CaiR.CraneE.PoneleitK.PaulozziL.2010Emergency department visits involving nonmedical use of selected prescription drugs in the United States, 2004–2008. Journal of Pain and Palliative Care Pharmacotherapy, 24 (3), 293–297.
CiceroT. J.EllisM. S.ParadisA.OrtbalZ.2010Determinants of fentanyl and other potent μ opioid agonist misuse in opioid-dependent individuals. Pharmacoepidemiology and Drug Safety, 19 (1), 1–7.
10.
CiceroT. J.SurrattH.InciardiJ. A.2007Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban and urban locations in the United States. Pharmacoepidemiology and Drug Safety, 16 (8), 827–840.
11.
CooperJ. R.CzechowiczD. J.PetersenR. C.MolinariS. P.1992Prescription drug diversion control and medical practice. Journal of the American Medical Association, 268 (10), 1306–1310.
12.
DartR. C.2009Monitoring risk: Post marketing surveillance and signal detection. Drug and Alcohol Dependence, 105 (Suppl 1), S26–S32.
13.
DasguptaN.SchnollS. H.2009Signal detection in post-marketing surveillance for controlled substances. Drug and Alcohol Dependence, 105 (Suppl 1), S33–S41.
14.
DennisM. L.TitusJ. C.WhiteM. K.UnsickerJ. I.HodgkinsD.2002Global Appraisal of Individual Needs - Initial (GAIN-I). Bloomington, IL: Chestnut Health Systems.
15.
General Accounting Office, U.S.2003OxyContin Abuse and Diversion and Efforts to Address the Problem [Report to Congressional Requesters, #GAO-04–110]. Washington, DC: U.S. Government Printing Office.
16.
HaaseC. M.SilbereisenR. K.2010Effects of positive affect on risk perceptions in adolescence and young adulthood. Journal of Adolescence, 34 (1), 29–37.
17.
HochstimJ.1967A critical comparison of three strategies of collecting data from households. Journal of the American Statistical Association, 62, 976–989.
18.
HollingerR. C.DabneyD. A.2002Social factors associated with pharmacist's unauthorized use of mind-altering prescription medications. Journal of Drug Issues, 32 (1), 231–264.
19.
InciardiJ. A.2005Trends in the Diversion of Prescription Drugs. Paper presented at the 16th Annual Training Conference of the National Association of Drug Diversion Investigators, Myrtle Beach, SC.
20.
InciardiJ. A.SurrattH. L.2005Researching the Abuse and Diversion of Prescription Drugs. Paper presented at the Abbott Laboratories Symposium on Prescription Drug Abuse, Chicago.
21.
InciardiJ. A.SurrattH. L.CiceroT. J.RosenblumA.AhwayC.BaileyJ. E.DartR. C.BurkeJ. J.2010Prescripton drugs purchased through the Internet: who are the end users?Drug and Alcohol Dependence, 110 (1–2), 21–29.
22.
InciardiJ. A.SurrattH. L.StiversY.CiceroT. J.2009FDA approvals of generic drugs: Impact on the diversion of opioid analgesics with a potential for abuse. Journal of Opioid Management, 5 (2), 81–87.
23.
JohansonC. E.BalsterR. L.HenningfieldJ. E.SchusterC. R.AnthonyJ. C.BarthwellA. G.ColemanJ. J.DartR. C.GorodetzkyC. W.O'KeeffeC. O.SellersE. M.VocciF.WalshS. L.2009Risk management and post-marketing surveillance for the abuse of medications acting on the central nervous system: Expert panel report. Drug and Alcohol Dependence, 105 (Suppl 1), S33–S41.
24.
LeidermanD. B.2009Risk management of drug products and the U. S. Food and Drug Administration: Evolution and context. Drug and Alcohol Dependence, 105 (Suppl 1), S9–S13.
25.
ManchikantiL.FellowsB.AilinaniH.PampatiV.2010Therapuetic use, abuse and nonmedical use of opioids: A ten-year perspective. Pain Physician, 13 (5), 401–435.
26.
McCabeS. E.TeterC. J.BoydC. J.2004The use, misuse and diversion of prescription stimulants among middle and high school students. Substance Use and Misuse, 39 (7), 1095–1116.
27.
McCormickC. G.2006Regulatory challenges for new formulations of controlled substances in today's environment. Drug and Alcohol Dependence, 83 (Suppl 1), S63–S67).
28.
MonheitB.2010Prescription drug misuse. Australian Family Physician, 39 (8), 540–546.
29.
NADDI, National Association of Drug Diversion Investigators2005aRxPatrol Alert: Delivered Drugs Stolen-Wisconsin. 3–7–2005.
30.
NADDI, National Association of Drug Diversion Investigators2005bRxPatrol Alert: Stolen Prescription Blanks-Texas. 3–2–2005.
31.
NADDI, National Association of Drug Diversion Investigators2005cRxPatrol Alert: Pharmacy Robbery-Florida, North Melbourne. 3–2–2005.
32.
NADDI, National Association of Drug Diversion Investigators2005dRxPatrol Alert: Pharmacy Burglary-Massachusetts, Peabody. 3–2–2005.
33.
OkamotoK.OhsukaK.ShiraishiT.HukazawaE.WakasugiS.FurutaK.2002Comparability of epidemiological information between self- and interviewer-administered questionnaires. Journal of Clinical Epidemiology, 55 (5), 505–511.
34.
PaulozziL. J.LoganJ. E.HallA. J.McKinstryE.KaplanJ. A.CrosbyA. E.2009A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia. Addiction, 104 (9), 1541–1548.
35.
RiggK. K.MarchS. J.InciardiJ. A.2010Prescription drug abuse & diversion: Role of the pain clinic. Journal of Drug Issues, 40 (3), 681–702.
36.
RoblingM. R.IngledewD. K.GreeneG.SayersA.ShawC.SanderL.RussellI. T.WilliamsJ. G.HoodK.2010Applying an extended theoretical framework for data collection mode to health services research. BMC Health Services Research, 10, 180.
37.
RuetschC.2010Empirical view of opioid dependence. Journal of Managed Care Pharmacy, 16 (1Suppl B), S9–S13.
38.
SaleJ. E.ThielkeS.Topolovec-VranicJ.2010Who is addicted to, and dying from, prescription opioids?Journal of the American Geriatrics Society, 58 (7), 1401–1402.
39.
SapienzaF. L.2006Abuse deterrent formulations and the Controlled Substances Act (CSA). Drug and Alcohol Dependence, 83 (Suppl 1), S23–S30.
40.
Simoni-WastilaL.TompkinsC.2001Balancing Diversion Control and Medical Necessity: The Case of Prescription Drugs with Abuse Potential. Substance Use and Misuse, 36 (9&10), 1275–1296.
41.
SpillerH.BaileyJ. E.DartR. C.SpillerS. S.2010Investigation of temporal changes of abuse and misuse of prescription opioids. Journal of Addictive Diseases, 29 (1), 78–83.
42.
SprouleB.BrandsB.LiS.Catz-BiroL.2009Changing patterns in opioid addiction: Characterizing users of oxycodone and other opioids. Canadian Family Physician, 55 (1), 68–69, 69.e1–5.
43.
StrasselsS. A.2009Economic Burden of prescription opioid misuse and abuse. Journal of Managed Care Pharmacy, 15 (7), 556–562.
44.
TourangeauR.SmithT. W.1996Asking sensitive questions: The impact of data collection mode, question format, and question context. Public Opinion Quarterly, 60, 275–304.
45.
TrinkoffA. M.StorrC. L.WallM. P.1999Prescription-type drug misuse and workplace access among nurses. Journal of Addictive Diseases, 18 (1), 9–17.
46.
TrinkoffA. M.ZhouQ.StorrC. L.SoekenK. L.2000Workplace access, negative proscriptions, job strain, and substance use in registered nurses. Nursing Research, 49 (2), 83–90.
47.
WeathermonR. A.1999Controlled substances diversion: Who attempts it and how. U.S. Pharmacist, 24 (12), 32–47.
48.
WeirE.2000Substance abuse among physicians. Journal of Ayub Medical College, 162 (12), 1730.
49.
WilfordB. B.FinchJ.CzechowiczD. J.WarrenD.1994An overview of prescription drug misuse and abuse: Defining the problem and seeking solutions. The Journal of Law, Medicine & Ethics, 22 (3), 197–203.
50.
ZacnyJ.BigelowG.ComptonP.FoleyK.IguchiM.SannerudC.2003College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: Position statement. Drug and Alcohol Dependence, 69 (3), 215–232.
